| Robust T-cell responses in anti-CD20-treated patients following COVID-19 vaccination: a prospective cohort study N Madelon, K Lauper, G Breville, I Sabater Royo, R Goldstein, DO Andrey, ... Clinical Infectious Diseases 75 (1), e1037-e1045, 2022 | 104 | 2022 |
| Omicron-specific cytotoxic T-cell responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with ocrelizumab N Madelon, N Heikkilä, IS Royo, P Fontannaz, G Breville, K Lauper, ... JAMA neurology 79 (4), 399-404, 2022 | 66 | 2022 |
| COVID‐19 encephalopathy: Clinical and neurobiological features M Uginet, G Breville, F Assal, KO Lövblad, MI Vargas, J Pugin, J Serratrice, ... Journal of Medical Virology 93 (7), 4374-4381, 2021 | 45 | 2021 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 33 | 2022 |
| Cerebrovascular complications and vessel wall imaging in COVID-19 encephalopathy—a pilot study M Uginet, G Breville, J Hofmeister, P Machi, PH Lalive, A Rosi, A Fitsiori, ... Clinical neuroradiology, 1-7, 2021 | 31 | 2021 |
| Short-term glucocorticoid-related side effects and adverse reactions: a narrative review and practical approach S Noetzlin, G Breville, JD Seebach, G Gastaldi Swiss medical weekly 152 (0102), w30088-w30088, 2022 | 25 | 2022 |
| Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients N Madelon, N Heikkilä, I Sabater Royo, P Fontannaz, G Breville, K Lauper, ... MedRxiv, 2021.12. 20.21268128, 2021 | 17 | 2021 |
| Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines N Madelon, K Lauper, G Breville, IS Royo, R Goldstein, DO Andrey, ... MedRxiv, 2021.07. 21.21260928, 2021 | 15 | 2021 |
| Interleukin 8, a biomarker to differentiate Guillain-Barré syndrome from CIDP G Breville, AM Lascano, P Roux-Lombard, N Vuilleumier, PH Lalive Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1031, 2021 | 14 | 2021 |
| IL-8 as a potential biomarker in Guillain-Barre Syndrome G Breville, AM Lascano, P Roux-Lombard, PH Lalive European cytokine network 30, 130-134, 2019 | 13 | 2019 |
| Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis C Alberto, C Deffert, N Lambeng, G Breville, A Gayet-Ageron, P Lalive, ... Microbiology Spectrum 10 (1), e01477-21, 2022 | 10 | 2022 |
| C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy A Rhally, A Griffa, S Kremer, M Uginet, G Breville, P Stancu, F Assal, ... Journal of Neural Transmission 128, 1899-1906, 2021 | 9 | 2021 |
| Brainstem progressive multifocal leukoencephalopathy G Breville, IJ Koralnik, PH Lalive European journal of neurology 28 (3), 1016-1021, 2021 | 7 | 2021 |
| Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection A Nuber-Champier, A Cionca, G Breville, P Voruz, IJ de Alcântara, G Allali, ... Psychoneuroendocrinology 153, 106104, 2023 | 6 | 2023 |
| Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase A Nuber-Champier, P Voruz, IJ de Alcântara, G Breville, G Allali, ... Brain, behavior, & immunity-health 26, 100511, 2022 | 6 | 2022 |
| Case report: severe complement-mediated thrombotic microangiopathy in IgG4-related disease secondary to anti-factor H IgG4 autoantibodies G Breville, I Zamberg, S Sadallah, C Stephan, B Ponte, JD Seebach Frontiers in Immunology 11, 604759, 2021 | 6 | 2021 |
| Does endothelial vulnerability in OSA syndrome promote COVID-19 encephalopathy? G Breville, D Adler, M Uginet, F Assal, R Tamisier, PH Lalive, JL Pepin, ... Chest 160 (2), e161-e164, 2021 | 5 | 2021 |
| Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy-A Pilot Study. Clin Neuroradiol. 2021 M Uginet, G Breville, J Hofmeister, P Machi, PH Lalive, A Rosi, A Fitsiori, ... | 5 | 2021 |
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells M Benkhoucha, NL Tran, G Breville, I Senoner, C Jandus, P Lalive Cellular & Molecular Immunology 18 (8), 2051-2053, 2021 | 4 | 2021 |
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation M Benkhoucha, NL Tran, G Breville, I Senoner, PF Bradfield, ... Journal of neuroinflammation 19 (1), 103, 2022 | 3 | 2022 |
